Tech Company Financing Transactions

Rgenta Therapeutics Funding Round

On 11/29/2022, Rgenta Therapeutics raised $52 million in Series A funding from AstraZeneca, Delos Capital and Korea Investment Partners.

Transaction Overview

Announced On
11/29/2022
Transaction Type
Venture Equity
Amount
$52,000,000
Round
Series A
Proceeds Purpose
The company plans to use the funding to speed up the development of the lead programs, enhance target discovery, extend platform capabilities, and advance a pipeline of RNA-targeting programs against a range of disease indications.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
700 Main St. LabCentral
Cambridge, MA 02139
USA
Phone
Undisclosed
Email Address
Overview
Rgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders. Our proprietary platform mines the massive genomics data to identify targetable RNA processing events and design small-molecule glues to modulate the interactions among the spliceosome, regulatory proteins, and RNAs.
Profile
Rgenta Therapeutics LinkedIn Company Profile
Social Media
Rgenta Therapeutics Company Twitter Account
Company News
Rgenta Therapeutics News
Facebook
Rgenta Therapeutics on Facebook
YouTube
Rgenta Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Simon Xi
  Simon Xi LinkedIn Profile  Simon Xi Twitter Account  Simon Xi News  Simon Xi on Facebook
Chief Scientific Officer
Travis Wager
  Travis Wager LinkedIn Profile  Travis Wager Twitter Account  Travis Wager News  Travis Wager on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/29/2022: Saltbox venture capital transaction
Next: 11/29/2022: Range Energy venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to document funding rounds that are announced publicly. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary